Research ArticleTUMOR IMMUNOLOGY

Targeted deletion of PD-1 in myeloid cells induces antitumor immunity

See allHide authors and affiliations

Science Immunology  03 Jan 2020:
Vol. 5, Issue 43, eaay1863
DOI: 10.1126/sciimmunol.aay1863

Article Information

vol. 5 no. 43

PubMed: 
Published By: 
History: 
  • Received May 29, 2019
  • Accepted November 13, 2019
  • .

Author Information

  1. Laura Strauss1,2,3,
  2. Mohamed A. A. Mahmoud1,2,3,*,
  3. Jessica D. Weaver1,2,3,
  4. Natalia M. Tijaro-Ovalle1,2,3,
  5. Anthos Christofides1,2,3,
  6. Qi Wang1,2,3,
  7. Rinku Pal1,2,3,
  8. Min Yuan3,
  9. John Asara3,
  10. Nikolaos Patsoukis1,2,3 and
  11. Vassiliki A. Boussiotis1,2,3,
  1. 1Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  2. 2Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  3. 3Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  1. Corresponding author. Email: vboussio{at}bidmc.harvard.edu
  • * Present address: Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Altmetric

Article usage

Article usage: December 2019 to January 2020

AbstractFullPdf
Dec 2019021
Jan 20201802287307366

Stay Connected to Science Immunology